High impact
Prior Authorization Changes to Oncology-related Codes
Highmark·Effective May 1, 2026
HCPCS J0207 is officially defined as "Injection, amifostine, 500 mg." HCPCS J0207 is referenced in 1 tracked payer policy change from Highmark. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0207 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.